Immix Biopharma Inc.

IMMX | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.22

-$0.28 (-2.24%)

Sep 21, 2026, 11:55 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.24%

(1D)

Rating

Updated: Sep 8, 2026

14.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $665.06M

1D Range

12.19 12.60

52W Range

1.98 15.10

Valuation (TTM)

PE -14.20

PB 2.97

EV/EBITDA -11.09

Valuation (NTM)

Forward PE 7.73

Forward PEG -0.75

Price Target $23.33

Cash Flow

FCF Yield -5.8%

SBC Adj. FCF Yield -6.1%

SBC Impact -5.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -1.2% | 36.4%

FCF 3Y | 5Y -52.6% | -45.3%

Returns

ROA -16.7%

ROE -38.4%

ROIC -18.2%

Financial Health

Net Cash

$231.11M

Current Ratio 25.13

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas ar...

Sector Healthcare

Industry Biotechnology

Employees 21

IPO Date Dec 15, 2021

Website www.immixbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$25

Upside

+104.58%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞